Literature DB >> 26385972

A Review of X-linked Charcot-Marie-Tooth Disease.

Ying Wang1, Fei Yin2.   

Abstract

X-linked Charcot-Marie-Tooth disease (CMTX) is the second common genetic variant of CMT. CMTX type 1 causes 90% of CMTX. The most important clinical features of CMTX are similar with other types of CMT; however, a few patients get the central nervous system involved with or without white matter lesions; males are more severely and earlier affected than females. In this review, the authors focus on the origin and classification of CMTX, the central nervous system manifestations of CMTX1, the possible mechanism by which GJB1 mutations cause CMT1X, and the emerging therapeutic strategies for CMTX. Moreover, several cases are presented to illustrate the central nervous system manifestations.
© The Author(s) 2015.

Entities:  

Keywords:  Charcot-Marie-Tooth disease; X-linked; central nervous system manifestations; therapeutic strategies; white matter lesions

Mesh:

Substances:

Year:  2015        PMID: 26385972     DOI: 10.1177/0883073815604227

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  15 in total

1.  An 8-generation family with X-linked Charcot-Marie-Tooth: Confirmation Of the pathogenicity Of a 3' untranslated region mutation in GJB1 and its clinical features.

Authors:  Dong-Hui Chen; Maxwell Ma; Mena Scavina; Elizabeth Blue; John Wolff; Prasanthi Karna; Michael O Dorschner; Wendy H Raskind; Thomas D Bird
Journal:  Muscle Nerve       Date:  2017-12-28       Impact factor: 3.217

2.  Reversible lesions of the corpus callosum with initially restricted diffusion in a series of Caucasian children.

Authors:  Anthony Le Bras; Maia Proisy; Mathieu Kuchenbuch; Constantin Gomes; Catherine Tréguier; Sylvia Napuri; Emmanuel Quehen; Bertrand Bruneau
Journal:  Pediatr Radiol       Date:  2018-04-17

Review 3.  Human diseases associated with connexin mutations.

Authors:  Miduturu Srinivas; Vytas K Verselis; Thomas W White
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-04-27       Impact factor: 3.747

4.  Fits, feet and HIV: lessons from a case of coexisting epilepsy and neuropathy in a patient with perinatally acquired HIV-1 infection.

Authors:  Nell Freeman-Romilly; Leena Mewasingh; Annette Coomer; Caroline Foster
Journal:  BMJ Case Rep       Date:  2018-10-16

5.  Clinical and Genetic Features of Chinese X-linked Charcot-Marie-Tooth Type 1 Disease.

Authors:  Yuan-Yuan Lu; He Lyu; Su-Qin Jin; Yue-Huan Zuo; Jing Liu; Zhao-Xia Wang; Wei Zhang; Yun Yuan
Journal:  Chin Med J (Engl)       Date:  2017-05-05       Impact factor: 2.628

6.  Coexistence of Amyotrophic Lateral Sclerosis in the Proband of an X-Linked Charcot-Marie-Tooth Disease Type 1 Pedigree in China.

Authors:  Shu Yan Feng; Shu Man Feng; Liu Yi Li; Zhang Yu Zou
Journal:  J Clin Neurol       Date:  2018-04       Impact factor: 3.077

7.  Melatonin Treatment Reduces Oxidative Damage and Normalizes Plasma Pro-Inflammatory Cytokines in Patients Suffering from Charcot-Marie-Tooth Neuropathy: A Pilot Study in Three Children.

Authors:  Mariam Chahbouni; María Del Señor López; Antonio Molina-Carballo; Tomás de Haro; Antonio Muñoz-Hoyos; Marisol Fernández-Ortiz; Ana Guerra-Librero; Darío Acuña-Castroviejo
Journal:  Molecules       Date:  2017-10-14       Impact factor: 4.411

8.  GJB1 Gene Analysis in Two Extended Families with X-Linked Charcot-Marie-Tooth Disease.

Authors:  Sabine Kovale; Ruta Terauda; Elina Millere; Gita Taurina; Daiga Murmane; Jekaterina Isakova; Viktorija Kenina; Linda Gailite
Journal:  Case Rep Neurol       Date:  2021-06-23

Review 9.  What's the Function of Connexin 32 in the Peripheral Nervous System?

Authors:  Mario Bortolozzi
Journal:  Front Mol Neurosci       Date:  2018-07-10       Impact factor: 5.639

10.  The Electrophysiological Features in X-Linked Charcot-Marie-Tooth Disease With Transient Central Nervous System Deficits.

Authors:  Qingxian Wen; Longqiao Cao; Cun Yang; Yanchen Xie
Journal:  Front Neurol       Date:  2018-06-27       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.